Id |
Subject |
Object |
Predicate |
Lexical cue |
T0 |
0-15 |
NNS |
denotes |
Vulnerabilities |
T1 |
16-18 |
IN |
denotes |
in |
T2 |
19-30 |
NN |
denotes |
coronavirus |
T3 |
31-37 |
NN |
denotes |
glycan |
T4 |
38-45 |
NNS |
denotes |
shields |
T5 |
46-53 |
IN |
denotes |
despite |
T6 |
54-63 |
JJ |
denotes |
extensive |
T7 |
64-77 |
NN |
denotes |
glycosylation |
T8 |
79-87 |
NN |
denotes |
Abstract |
T9 |
88-94 |
JJ |
denotes |
Severe |
T10 |
95-100 |
JJ |
denotes |
acute |
T11 |
101-112 |
JJ |
denotes |
respiratory |
T12 |
113-121 |
NN |
denotes |
syndrome |
T13 |
122-123 |
-LRB- |
denotes |
( |
T14 |
123-127 |
NN |
denotes |
SARS |
T15 |
127-128 |
-RRB- |
denotes |
) |
T16 |
129-132 |
CC |
denotes |
and |
T17 |
133-139 |
NNP |
denotes |
Middle |
T18 |
140-144 |
NNP |
denotes |
East |
T19 |
145-156 |
JJ |
denotes |
respiratory |
R0 |
T0 |
T1 |
arg1Of |
Vulnerabilities,in |
R1 |
T4 |
T1 |
arg2Of |
shields,in |
R10 |
T12 |
T13 |
arg1Of |
syndrome,( |
R11 |
T14 |
T13 |
arg2Of |
SARS,( |
R12 |
T15 |
T13 |
arg3Of |
),( |
R13 |
T12 |
T16 |
arg1Of |
syndrome,and |
R15 |
T18 |
T17 |
arg1Of |
East,Middle |
R2 |
T4 |
T2 |
arg1Of |
shields,coronavirus |
R3 |
T4 |
T3 |
arg1Of |
shields,glycan |
R4 |
T0 |
T5 |
arg1Of |
Vulnerabilities,despite |
R5 |
T7 |
T5 |
arg2Of |
glycosylation,despite |
R6 |
T7 |
T6 |
arg1Of |
glycosylation,extensive |
R7 |
T12 |
T9 |
arg1Of |
syndrome,Severe |
R8 |
T12 |
T10 |
arg1Of |
syndrome,acute |
R9 |
T12 |
T11 |
arg1Of |
syndrome,respiratory |